Related Experiment Video
Updated: Jun 1, 2026

06:29
Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin
Published on: March 3, 2021
5.5K
Quantum-assisted fragment-based automated structure generator (QFASG) for small molecule design: an in vitro study
Sergei Evteev1, Yan Ivanenkov1, Ivan Semenov1
1Insilico Medicine Hong Kong Ltd., Hong Kong, Hong Kong SAR, China.
Frontiers in Chemistry
|April 18, 2024
Summary
A new Quantum-assisted Fragment-based Automated Structure Generator (QFASG) algorithm successfully designed novel low-micromolar inhibitors for CAMKK2 and ATM targets. This AI-driven approach enhances automated drug discovery and virtual fragment-based design capabilities.
Area of Science:
- Computational chemistry
- Drug discovery
- Artificial intelligence in medicine
Background:
- Automated drug design using virtual generative models is increasingly important.
- AI-driven generative chemistry platforms have shown limited success in producing valuable structures.
- Virtual fragment-based drug design is gaining traction due to advancements in chemoinformatics and computing power.
Purpose of the Study:
- To develop and evaluate a novel automated algorithm for generating drug-like molecules.
- To design new inhibitors for the CAMKK2 and ATM proteins using the developed algorithm.
Main Methods:
- Development of the Quantum-assisted Fragment-based Automated Structure Generator (QFASG) algorithm.
- Utilizing a library of molecular fragments to construct ligands for target proteins.
- Application of QFASG for generating novel CAMKK2 and ATM inhibitors.
Main Results:
- Successful design of new low-micromolar inhibitors for CAMKK2.
- Successful design of new low-micromolar inhibitors for ATM.
- Demonstration of QFASG's capability in generating potent drug candidates.
Conclusions:
- The QFASG algorithm shows significant potential for designing initial hit compounds in drug discovery.
- QFASG represents an effective tool for AI-assisted virtual fragment-based drug design.
- The developed method can accelerate the identification of novel therapeutic agents.

